Webster Financial Earnings Call Transcripts
Fiscal Year 2026
-
Stockholders approved the acquisition by Banco Santander and related executive compensation. The board and management expressed gratitude for stakeholder support, and final voting results will be filed with the SEC.
Fiscal Year 2025
-
Delivered record 2025 results with double-digit EPS and tangible book value growth, strong loan and deposit expansion, and robust capital returns. 2026 guidance calls for continued growth, stable NIM, and further HSA-driven deposit gains, with risk well-managed and capital ratios above targets.
-
The bank delivered strong financial results in 2025, with robust loan and deposit growth, and stabilized credit quality. Strategic focus remains on profitable growth, leveraging a diversified funding base, expanding healthcare-related deposits, and maintaining operational efficiency. Regulatory changes are expected to ease compliance costs, supporting further investment and capital return.
-
Q3 delivered strong profitability with 18% ROTCE, 2%+ loan and deposit growth, and higher revenue. Asset quality improved, capital ratios remain robust, and strategic initiatives like the HSA Bank expansion and private credit JV are progressing well.
-
Strong financial performance continues, driven by a diversified deposit base and strategic partnerships like the Marathon Asset Management JV. Credit quality is improving, regulatory changes could provide further upside, and growth is focused on healthcare verticals and digital capabilities.
-
Q2 saw strong growth in loans, deposits, and revenue, with improved asset quality and robust capital. HSA Bank's addressable market is expanding, and the Marathon JV is set to drive future fee income. NIM is expected to end 2025 between 3.35% and 3.40%.
-
Solid Q1 results featured strong deposit and loan growth, stable NIM, and robust capital. Credit quality challenges were concentrated in healthcare and office CRE, but overall asset quality trends are stabilizing. Full-year guidance and capital return plans remain intact.
-
Management highlighted strong deposit franchises, a positive economic outlook, and strategic focus on healthcare financial services and infrastructure investment. Loan growth and margin guidance remain steady, with credit quality expected to stabilize in 2025.
Fiscal Year 2024
-
Delivered strong Q4 and full-year results with robust loan and deposit growth, improved efficiency, and a solid capital position. Strategic actions included reducing CRE exposure, acquiring Ametros, and investing in technology. 2025 guidance calls for 4%-5% growth in loans and deposits, stable margins, and continued expense discipline.
-
Q3 saw strong deposit and loan growth, improved capital ratios, and industry-leading efficiency. CRE exposure was further reduced, with office loans driving most charge-offs, but reserves remain robust. Guidance calls for modest loan growth and stable profitability into 2025.
-
Q2 2024 saw strong deposit and loan growth, stable credit metrics despite office loan stress, and improved securities yields following a portfolio repositioning. Guidance calls for 4%-5% loan growth and 5% deposit growth for the year, with a CET1 target of 11% by year-end.